About Alagille syndrome due to 20p12 microdeletion
Alagille syndrome due to 20p12 microdeletion is a rare disease catalogued by Orphanet (ORPHA:261600). It is associated with the JAG1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Alagille syndrome due to 20p12 microdeletion trials.
Search ClinicalTrials.gov for "Alagille syndrome due to 20p12 microdeletion" or filter by Orphanet code ORPHA:261600 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Alagille syndrome due to 20p12 microdeletion trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Alagille syndrome due to 20p12 microdeletion. Updated daily.